Adenosine Injection, Solution
Product Images NDC 55150-193

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 55150-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

General Formula (Adenosine Fig1)

This appears to be a medical calculation involving infusion rate for Adenosine injection based on the patient's total body weight and the concentration of the injection. The result of the calculation is not provided in the given text.*

FDA Label Image

Package Label-principal Display Panel (60 mg per 20 mL (3 mg / mL))

This is a description of Adenosine Injection, USP, a medication given via intravenous infusion to treat abnormal heart rhythms. Each 20 mL single dose vial contains Adenosine USP 3 mg and sodium chloride in water for injection. It is sterile, nonpyrogenic and has a pH between 4.5 and 7.5. The usual dosage is specified in the package insert. The solution must be clear and is not to be refrigerated to prevent crystalization. Adenosine Injection, USP is distributed by AuroMedics Pharma LLC and is made in India.*

FDA Label Image

Package Label-principal Display Panel (60 mg per 20 mL (3 mg / mL))

FDA Label Image

Package Label-principal Display Panel (90 mg per 30 mL (3 mg / mL))

Adenosine Injection, USP is a non-pyrogenic solution for intravenous infusion only, containing 3 mg/mL Adenosine USP and sodium chloride 9 mg in Water for Injection. It is supplied in single-dose vials of 20 mL each, with a total of 60 mg per vial. The pH of the solution is between 4.5 and 7.5. The solution should not be refrigerated as crystallization may occur, and any crystals should be dissolved by warming to room temperature. The solution must be clear at the time of use. The product is distributed by AuroMedics Pharma LLC and made in India. The usual dosage should be seen in the package insert. The vial stoppers are not made with natural rubber latex.*

FDA Label Image

Package Label-principal Display Panel (90 mg per 30 mL (3 mg / mL))

This is a description of a sterile, nonpyrogenic solution containing Adenosine USP 3mg and sodium chloride 9mg in water for injection with a pH between 4.5 and 7.5. The solution is for intravenous infusion only and contains no preservatives, and is available in a 30mL single-dose vial. It is important to store the product at 20°C to 25°C (68°F to 77°F) and should not be refrigerated as crystallization may occur. If crystallization happens, dissolve crystals by warming to room temperature. The solution must be clear at the time of use. Usual dosage must be followed, and the unused portion should be discarded. It is distributed by AuroMedics Pharma LLC and made in India with the code TS/DRUGS/13/2010.*

FDA Label Image

Adenosine Fig6

This is a description of an injection medication containing Adenosine USP 3mg and sodium chloride 9 mg in Water for Injection. The medication is for intravenous infusion only and comes in a 30 mL single-dose vial. It is nonpyrogenic and sterile. The solution must be clear at the time of use, and if crystallization occurs, it needs to be dissolved by warming to room temperature. The vial stopper is not made with natural rubber latex. The usual dosage information is available in the package insert. This medication is distributed by AuroMedics Pharma LLC and is made in India. The code is TS/DRUGS/13/2010, and the product number is 55150-193-01.*

FDA Label Image

Adenosine Fig7

The text describes a medication called Adenosine Injection, USP, a nonpyrogenic drug intended for intravenous infusion only. It comes in packs of 10 single-dose vials, each of 30 mL. Each Vial contains Adenosine USP 3 mg, sodium chloride 9 mg in Water for Injection q.5, and has a pH between 4.5 and 7.5. The text also gives information on how to store the medication, clarifying that it should not be refrigerated, and that if crystallization has occurred, the crystals should be dissolved by warming to room temperature. The solution should be clear at the time of use, and any unused portion should be discarded. The label includes the name of the pharmaceutical company distributing the medication, AuroMedics Pharma LLC.*

FDA Label Image

Adenosine Chemical Structure (Adenosine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.